{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:25:19Z","timestamp":1792045519391,"version":"4.4.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG027161"],"award-info":[{"award-number":["R01AG027161"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG037639"],"award-info":[{"award-number":["R01AG037639"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50AG033514"],"award-info":[{"award-number":["P50AG033514"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bbi.2026.106468","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T23:27:37Z","timestamp":1769470057000},"page":"106468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Higher CSF sTREM2 is related to slower hippocampal atrophy and cognitive decline independently of pTau181 levels"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8340-1162","authenticated-orcid":false,"given":"Henry Gilreath","family":"Stephenson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobey J.","family":"Betthauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Jonaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol Van","family":"Hulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendlyn","family":"Kollmorgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Quijano-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ewers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannis","family":"Denecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler K.","family":"Ulland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel A.","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozioma C.","family":"Okonkwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Asthana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sterling C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara B.","family":"Bendlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbi.2026.106468_b0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the national institute on aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.bbi.2026.106468_b0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuroimage.2007.07.007","article-title":"A fast diffeomorphic image registration algorithm","volume":"38","author":"Ashburner","year":"2007","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.bbi.2026.106468_b0015","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuroimage.2005.02.018","article-title":"Unified segmentation","volume":"26","author":"Ashburner","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.bbi.2026.106468_b0020","first-page":"197","article-title":"Symmetric diffeomorphic modeling of longitudinal structural MRI","volume":"6","author":"Ashburner","year":"2012","journal-title":"Front. Neurosci."},{"issue":"9","key":"10.1016\/j.bbi.2026.106468_b0025","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbi.2026.106468_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J. Stat. Softw."},{"issue":"56","key":"10.1016\/j.bbi.2026.106468_b0035","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.21105\/joss.02815","article-title":"Effectsize: estimation of effect size indices and standardized parameters","volume":"5","author":"Ben-Shachar","year":"2020","journal-title":"J. Open Source Softw."},{"issue":"4","key":"10.1016\/j.bbi.2026.106468_b0040","doi-asserted-by":"crossref","first-page":"934.e7-10","DOI":"10.1016\/j.neurobiolaging.2013.09.017","article-title":"Heterozygous TREM2 mutations in frontotemporal dementia","volume":"35","author":"Borroni","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.bbi.2026.106468_b0045","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neuron.2021.12.016","article-title":"Soluble TAM receptors sAXL and sTyro3 predict structural and functional protection in Alzheimer\u2019s disease","volume":"110","author":"Brosseron","year":"2022","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.bbi.2026.106468_b0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13024-018-0262-8","article-title":"The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer\u2019s disease","volume":"13","author":"Cheng-Hathaway","year":"2018","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.bbi.2026.106468_b0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.bbi.2026.106468_b0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-025-02961-x","article-title":"Neuroimaging-derived biological brain age and its associations with glial reactivity and synaptic dysfunction cerebrospinal fluid biomarkers","author":"Cumplido-Mayoral","year":"2025","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2026.106468_b0065","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","article-title":"Disease-associated microglia: a universal immune sensor of neurodegeneration","volume":"173","author":"Deczkowska","year":"2018","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bbi.2026.106468_b0070","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","article-title":"An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest","volume":"31","author":"Desikan","year":"2006","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.bbi.2026.106468_b0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s13311-022-01185-z","article-title":"Heterogeneity in Alzheimer\u2019s disease diagnosis and progression rates: implications for therapeutic trials","volume":"19","author":"Duara","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.bbi.2026.106468_b0080","article-title":"A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer\u2019s disease","volume":"12","author":"Edwin","year":"2020","journal-title":"Alzheimers Dement. (Amst)."},{"issue":"507","key":"10.1016\/j.bbi.2026.106468_b0085","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav6221","article-title":"Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer\u2019s disease","volume":"11","author":"Ewers","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.bbi.2026.106468_b0090","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012308","article-title":"Higher CSF sTREM2 and microglia activation are associated with slower rates of beta-amyloid accumulation","volume":"12","author":"Ewers","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbi.2026.106468_b0095","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nicl.2018.04.016","article-title":"Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer\u2019s disease: a study of two independent datasets","volume":"19","author":"Falcon","year":"2018","journal-title":"Neuroimage Clin."},{"issue":"5","key":"10.1016\/j.bbi.2026.106468_b0100","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.immuni.2018.04.016","article-title":"The microglial innate immune receptor TREM2 is required for synapse elimination and normal brain connectivity","volume":"48","author":"Filipello","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.bbi.2026.106468_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105630","article-title":"Soluble TREM2: innocent bystander or active player in neurological diseases?","volume":"165","author":"Filipello","year":"2022","journal-title":"Neurobiol. Dis."},{"issue":"12","key":"10.1016\/j.bbi.2026.106468_b0110","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/j.neurobiolaging.2013.05.001","article-title":"Insights into TREM2 biology by network analysis of human brain gene expression data","volume":"34","author":"Forabosco","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.bbi.2026.106468_b0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-020-00407-2","article-title":"Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration","volume":"15","author":"Franzmeier","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"7","key":"10.1016\/j.bbi.2026.106468_b0120","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1176\/appi.ajp.162.7.1256","article-title":"Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder","volume":"162","author":"Frazier","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.bbi.2026.106468_b0125","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.biopsych.2006.06.027","article-title":"Hypothalamic abnormalities in schizophrenia: sex effects and genetic vulnerability","volume":"61","author":"Goldstein","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.bbi.2026.106468_b0130","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1172\/JCI138179","article-title":"Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration","volume":"130","author":"Gratuze","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bbi.2026.106468_b0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer\u2019s disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bbi.2026.106468_b0140","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/cercor\/bhz240","article-title":"CSF sTREM2 and Tau work together in predicting increased temporal lobe atrophy in older adults","volume":"30","author":"Halaas","year":"2020","journal-title":"Cereb. Cortex"},{"issue":"7","key":"10.1016\/j.bbi.2026.106468_b0145","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/alz.12249","article-title":"Distinct effects of beta-amyloid and tau on cortical thickness in cognitively healthy older adults","volume":"17","author":"Harrison","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbi.2026.106468_b0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-023-02387-3","article-title":"Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition","author":"Hayek","year":"2024","journal-title":"Mol. Psychiatry"},{"issue":"7434","key":"10.1016\/j.bbi.2026.106468_b0155","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bbi.2026.106468_b0160","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2026.106468_b0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-016-0071-x","article-title":"Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer\u2019s disease","volume":"11","author":"Heslegrave","year":"2016","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.bbi.2026.106468_b0170","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41398-025-03457-6","article-title":"Relationships of PGRN with sTREM2 in AD continuum and non-AD pathophysiology and their reciprocal roles in modulating amyloid pathology: two population-based study","volume":"15","author":"Huang","year":"2025","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2026.106468_b0175","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0165-5728(89)90115-X","article-title":"Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease","volume":"24","author":"Itagaki","year":"1989","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.bbi.2026.106468_b0180","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.bbi.2026.106468_b0185","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220654","article-title":"Chronic TREM2 activation exacerbates A\u03b2-associated tau seeding and spreading","volume":"220","author":"Jain","year":"2023","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.bbi.2026.106468_b0190","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s10753-018-0735-5","article-title":"TREM2 ameliorates neuronal tau pathology through suppression of microglial inflammatory response","volume":"41","author":"Jiang","year":"2018","journal-title":"Inflammation"},{"key":"10.1016\/j.bbi.2026.106468_b0195","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.dadm.2018.11.006","article-title":"Measuring longitudinal cognition: Individual tests versus composites","volume":"11","author":"Jonaitis","year":"2019","journal-title":"Alzheimers Dement. (Amst)"},{"issue":"5","key":"10.1016\/j.bbi.2026.106468_b0200","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1002\/alz.13774","article-title":"Longitudinal normative standards for cognitive tests and composites using harmonized data from two Wisconsin AD-risk-enriched cohorts","volume":"20","author":"Jonaitis","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.bbi.2026.106468_b0205","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer\u2019s disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bbi.2026.106468_b0210","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer\u2019s disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"issue":"243","key":"10.1016\/j.bbi.2026.106468_b0215","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009093","article-title":"TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis","volume":"6","author":"Kleinberger","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.bbi.2026.106468_b0220","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1212\/01.WNL.0000160304.00003.CA","article-title":"The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2","volume":"64","author":"Kl\u00fcnemann","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.bbi.2026.106468_b0225","doi-asserted-by":"crossref","first-page":"15886","DOI":"10.1038\/s41598-020-72878-8","article-title":"Cerebrospinal fluid sTREM2 in Alzheimer\u2019s disease: comparisons between clinical presentation and AT classification","volume":"10","author":"Knapskog","year":"2020","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.bbi.2026.106468_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v082.i13","article-title":"lmerTest package: tests in linear mixed effects models","volume":"82","author":"Kuznetsova","year":"2017","journal-title":"J. Stat. Softw."},{"issue":"524","key":"10.1016\/j.bbi.2026.106468_b0235","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau5732","article-title":"Prospective longitudinal atrophy in Alzheimer\u2019s disease correlates with the intensity and topography of baseline tau-PET","volume":"12","author":"La Joie","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.bbi.2026.106468_b0240","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.neuron.2018.02.002","article-title":"Elevated TREM2 gene dosage reprograms microglia responsivity and ameliorates pathological phenotypes in Alzheimer\u2019s disease models","volume":"97","author":"Lee","year":"2018","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.bbi.2026.106468_b0245","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.neuron.2021.02.010","article-title":"Trem2 restrains the enhancement of tau accumulation and neurodegeneration by \u03b2-amyloid pathology","volume":"109","author":"Lee","year":"2021","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.bbi.2026.106468_b0250","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3233\/JAD-220102","article-title":"Cerebrospinal fluid sTREM2 has paradoxical association with brain structural damage rate in early- and late-stage Alzheimer\u2019s disease","volume":"88","author":"Leng","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbi.2026.106468_b0255","unstructured":"Lenth, R.V., 2024. Emmeans: Estimated Marginal Means, Aka Least-Squares Means. https:\/\/CRAN.R-project.org\/package=emmeans."},{"issue":"43","key":"10.1016\/j.bbi.2026.106468_b0260","doi-asserted-by":"crossref","first-page":"11524","DOI":"10.1073\/pnas.1710311114","article-title":"TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy","volume":"114","author":"Leyns","year":"2017","journal-title":"PNAS"},{"issue":"8","key":"10.1016\/j.bbi.2026.106468_b0265","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41593-019-0433-0","article-title":"TREM2 function impedes tau seeding in neuritic plaques","volume":"22","author":"Leyns","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbi.2026.106468_b0270","article-title":"sjPlot: Data Visualization for Statistics","author":"L\u00fcdecke","year":"2024","journal-title":"Soc. Sci."},{"issue":"60","key":"10.1016\/j.bbi.2026.106468_b0275","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.21105\/joss.03139","article-title":"performance: an R package for assessment, comparison and testing of statistical models","volume":"6","author":"L\u00fcdecke","year":"2021","journal-title":"J. Open Source Softw."},{"issue":"2\u20133","key":"10.1016\/j.bbi.2026.106468_b0280","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.schres.2005.11.020","article-title":"Decreased volume of left and total anterior insular lobule in schizophrenia","volume":"83","author":"Makris","year":"2006","journal-title":"Schizophr. Res."},{"issue":"16","key":"10.1016\/j.bbi.2026.106468_b0285","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz2387","article-title":"A\u03b2 deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer\u2019s disease","volume":"6","author":"Mattsson-Carlgren","year":"2020","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.bbi.2026.106468_b0290","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the national institute on aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.bbi.2026.106468_b0295","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/WAD.0000000000000111","article-title":"Results from the NACC uniform data set neuropsychological battery crosswalk study","volume":"30","author":"Monsell","year":"2016","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"4","key":"10.1016\/j.bbi.2026.106468_b0300","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1474-4422(22)00027-8","article-title":"Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer\u2019s disease: a longitudinal observational study","volume":"21","author":"Morenas-Rodr\u00edguez","year":"2022","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.bbi.2026.106468_b0305","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1038\/s41591-022-02049-x","article-title":"Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline","volume":"28","author":"Ossenkoppele","year":"2022","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.bbi.2026.106468_b0310","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41593-018-0296-9","article-title":"Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE","volume":"22","author":"Parhizkar","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"Pt 11","key":"10.1016\/j.bbi.2026.106468_b0315","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/brain\/awn217","article-title":"Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation","volume":"131","author":"Piccio","year":"2008","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.bbi.2026.106468_b0320","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00401-016-1533-5","article-title":"Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status","volume":"131","author":"Piccio","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"50","key":"10.1016\/j.bbi.2026.106468_b0325","doi-asserted-by":"crossref","first-page":"9552","DOI":"10.1523\/JNEUROSCI.2193-20.2020","article-title":"Loss of TREM2 confers resilience to synaptic and cognitive impairment in aged mice","volume":"40","author":"Qu","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2026.106468_b0330","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2021"},{"issue":"8","key":"10.1016\/j.bbi.2026.106468_b0335","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jamaneurol.2018.0629","article-title":"Prevalence and outcomes of amyloid positivity among persons without dementia in a longitudinal, population-based setting","volume":"75","author":"Roberts","year":"2018","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.bbi.2026.106468_b0340","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.15252\/emmm.201707672","article-title":"An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function","volume":"9","author":"Schlepckow","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbi.2026.106468_b0345","unstructured":"M. Schmidt. Rey Auditory Verbal Learning Test\u00a0: RAVLT\u00a0: A Handbook. Western Psychological Services; 1996."},{"issue":"3","key":"10.1016\/j.bbi.2026.106468_b0350","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1084\/jem.20171529","article-title":"Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism","volume":"215","author":"Song","year":"2018","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.bbi.2026.106468_b0355","article-title":"Amyloid is associated with accelerated atrophy in cognitively unimpaired individuals","volume":"17","author":"Stephenson","year":"2025","journal-title":"Alzheimers Dement. (AMST)"},{"issue":"9","key":"10.1016\/j.bbi.2026.106468_bib421","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.31093","article-title":"Abnormal Amyloid-\u03b2 Duration, Tau, and Neurodegeneration in Cranial Images","volume":"8","author":"Stephenson","year":"2025","journal-title":"JAMA Netw. Open."},{"issue":"10","key":"10.1016\/j.bbi.2026.106468_b0360","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/jamaneurol.2022.2379","article-title":"Association of elevated amyloid and tau positron emission tomography signal with near-term development of Alzheimer disease symptoms in older adults without cognitive impairment","volume":"79","author":"Strikwerda-Brown","year":"2022","journal-title":"JAMA Neurol."},{"issue":"5","key":"10.1016\/j.bbi.2026.106468_b0365","doi-asserted-by":"crossref","first-page":"466","DOI":"10.15252\/emmm.201506123","article-title":"sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer\u2019s disease and associate with neuronal injury markers","volume":"8","author":"Su\u00e1rez-Calvet","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"369","key":"10.1016\/j.bbi.2026.106468_b0370","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1767","article-title":"Early changes in CSF sTREM2 in dominantly inherited Alzheimer\u2019s disease occur after amyloid deposition and neuronal injury","volume":"8","author":"Su\u00e1rez-Calvet","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.bbi.2026.106468_b0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-018-0301-5","article-title":"Early increase of CSF sTREM2 in Alzheimer\u2019s disease is associated with tau related-neurodegeneration but not with amyloid-\u03b2 pathology","volume":"14","author":"Su\u00e1rez-Calvet","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.bbi.2026.106468_b0380","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jamaneurol.2022.4485","article-title":"Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography","volume":"80","author":"Therriault","year":"2023","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.bbi.2026.106468_b0385","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuron.2017.02.042","article-title":"Elucidating the role of TREM2 in Alzheimer\u2019s disease","volume":"94","author":"Ulrich","year":"2017","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.bbi.2026.106468_b0390","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/alz.12204","article-title":"An examination of a novel multipanel of CSF biomarkers in the Alzheimer\u2019s disease clinical and pathological continuum","volume":"17","author":"Van Hulle","year":"2021","journal-title":"Alzheimers Dement."},{"issue":"5","key":"10.1016\/j.bbi.2026.106468_b0395","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20151948","article-title":"TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques","volume":"213","author":"Wang","year":"2016","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.bbi.2026.106468_b0400","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1002\/alz.13862","article-title":"CSF glial biomarkers are associated with cognition in individuals at risk of Alzheimer\u2019s disease","volume":"20","author":"Warmenhoven","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbi.2026.106468_b0405","unstructured":"D. Wechsler. WMS-R\u00a0: Wechsler Memory Scale--Revised\u00a0: Manual. Psychological Corp.\u00a0: Harcourt Brace Jovanovich; 1987."},{"issue":"43","key":"10.1016\/j.bbi.2026.106468_b0410","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw."},{"issue":"46","key":"10.1016\/j.bbi.2026.106468_b0415","doi-asserted-by":"crossref","first-page":"33027","DOI":"10.1074\/jbc.M113.517540","article-title":"Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and \u03b3-secretase-dependent intramembranous cleavage","volume":"288","author":"Wunderlich","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbi.2026.106468_b0420","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/s41467-019-09118-9","article-title":"Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer\u2019s disease model","volume":"10","author":"Zhong","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159126002163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159126002163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T16:08:23Z","timestamp":1775750903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159126002163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":85,"alternative-id":["S0889159126002163"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106468","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher CSF sTREM2 is related to slower hippocampal atrophy and cognitive decline independently of pTau181 levels","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106468"}}